326 related articles for article (PubMed ID: 24274066)
1. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
[TBL] [Abstract][Full Text] [Related]
2. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.
Lee MH; Kachroo P; Pagano PC; Yanagawa J; Wang G; Walser TC; Krysan K; Sharma S; John MS; Dubinett SM; Lee JM
J Cancer Sci Ther; 2014 Nov; 6(11):468-477. PubMed ID: 26523208
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 Inhibits Trophoblast Cell Invasion and Migration by Affecting the Epithelial-Mesenchymal Transition in Preeclampsia.
Ge H; Yin N; Han TL; Huang D; Chen X; Xu P; He C; Tong C; Qi H
Reprod Sci; 2019 Jul; 26(7):928-938. PubMed ID: 30373477
[TBL] [Abstract][Full Text] [Related]
4. IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
Dong Z; Tai W; Lei W; Wang Y; Li Z; Zhang T
BMC Cell Biol; 2016 Mar; 17():7. PubMed ID: 26932661
[TBL] [Abstract][Full Text] [Related]
5. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.
Zhang W; Wu X; Hu L; Ma Y; Xiu Z; Huang B; Feng Y; Tang X
Oncol Res; 2017 May; 25(5):843-852. PubMed ID: 28508744
[TBL] [Abstract][Full Text] [Related]
7. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
9. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
11. Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1-IL-8 signaling-mediated epithelial-mesenchymal transition in lung adenocarcinoma.
Yang X; Chen R; Chen Y; Zhou Y; Wu C; Li Q; Wu J; Hu WW; Zhao WQ; Wei W; Shi JT; Ji M
Cancer Sci; 2022 Apr; 113(4):1195-1207. PubMed ID: 35152527
[TBL] [Abstract][Full Text] [Related]
12. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
13. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
[TBL] [Abstract][Full Text] [Related]
15. The Root Bark of
Min TR; Park HJ; Park MN; Kim B; Park SH
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067694
[TBL] [Abstract][Full Text] [Related]
16. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
17. Mangiferin inhibits lipopolysaccharide-induced epithelial-mesenchymal transition (EMT) and enhances the expression of tumor suppressor gene PER1 in non-small cell lung cancer cells.
Lin YS; Tsai KL; Chen JN; Wu CS
Environ Toxicol; 2020 Oct; 35(10):1070-1081. PubMed ID: 32420661
[TBL] [Abstract][Full Text] [Related]
18. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
Geng F; Jiang Z; Song X; Zhou H; Zhao H
Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
[TBL] [Abstract][Full Text] [Related]
19. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
Wang M; Wang W; Ding J; Wang J; Zhang J
Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]